GMCSF

DRUG4 trials

Sponsors

SWOG Cancer Research Network, Institute of Liver and Biliary Sciences, India

Conditions

Brain TumorsCirrhosisGastric CancerOvarian CancerProstate CancerSpontaneous Bacterial Peritonitis

Phase 1

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

TerminatedNCT00023634

SWOG Cancer Research NetworkBrain Tumors, Gastric Cancer, Ovarian Cancer +1

Start: 2001-06-30End: 2008-11-30Updated: 2015-03-06

Unknown Phase

Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis

Institute of Liver and Biliary Sciences, IndiaCirrhosis

Start: 2017-04-19End: 2020-10-19Updated: 2020-02-20

Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis

CompletedNCT03702426

Institute of Liver and Biliary Sciences, IndiaSpontaneous Bacterial Peritonitis

Start: 2018-07-23End: 2019-07-31Updated: 2019-10-24

A Randomized Controlled Trial Comparing Imipenem and Tigecycline Versus Imipenem and Tigecycline With GM-CSF for the Management of Spontaneous Bacterial Peritonitis Presenting With Septic Shock.

Institute of Liver and Biliary Sciences, IndiaSpontaneous Bacterial Peritonitis

Start: 2019-12-20End: 2021-12-31Target: 90Updated: 2021-02-16